ConductScience.org, home

Paper20177397

Genomic instability--an evolving hallmark of cancer.

Negrini S and 2 others. Nat Rev Mol Cell Biol, 2010. Cited by 1,826 papers, by iCite.

Cite this record

ConductScience Library. Genomic instability--an evolving hallmark of cancer. Papers, record 20177397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20177397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genomic instability--an evolving hallmark of cancer.
PubMed
Journal
Nat Rev Mol Cell Biol
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
1,826
iCite
Relative citation ratio, by iCite
39.3
iCite
Revised in PubMed
2022-04-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Negrini SSimona
2Gorgoulis VGVassilis G
3Halazonetis TDThanos D

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genomic InstabilityMajor topic
MutationMajor topic
NeoplasmsMajor topic
Animals
Ataxia Telangiectasia Mutated Proteins
Cell Cycle Proteins
Cyclin-Dependent Kinase Inhibitor p16
DNA Damage
DNA-Binding Proteins
Humans
Models, Biological
Protein Serine-Threonine Kinases
Tumor Suppressor Protein p53
Tumor Suppressor Proteins

Source PubMed

Download CSV of topics

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118692126Design and analysis issues in genome-wide somatic mutation studies of cancer.Genomics2009https://conductscience.org/library/papers/18692126PubMed
215175263Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.Genes Dev2004https://conductscience.org/library/papers/15175263PubMed
32188735A genetic model for colorectal tumorigenesis.Cell1990https://conductscience.org/library/papers/2188735PubMed
42039987Mutator phenotype may be required for multistage carcinogenesis.Cancer Res1991https://conductscience.org/library/papers/2039987PubMed
517608616Chromosome fragile sites.Annu Rev Genet2007https://conductscience.org/library/papers/17608616PubMed
616839881DRAM, a p53-induced modulator of autophagy, is critical for apoptosis.Cell2006https://conductscience.org/library/papers/16839881PubMed
718772397Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.Science2008https://conductscience.org/library/papers/18772397PubMed
817932254The genomic landscapes of human breast and colorectal cancers.Science2007https://conductscience.org/library/papers/17932254PubMed
99778245Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.Cell1998https://conductscience.org/library/papers/9778245PubMed
1019434427Analytical methods for inferring functional effects of single base pair substitutions in human cancers.Hum Genet2009https://conductscience.org/library/papers/19434427PubMed
1118084328Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.Oncogene2008https://conductscience.org/library/papers/18084328PubMed
1217344846Patterns of somatic mutation in human cancer genomes.Nature2007https://conductscience.org/library/papers/17344846PubMed
138259215A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.Nature1993https://conductscience.org/library/papers/8259215PubMed
1416896009DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes.J Clin Oncol2006https://conductscience.org/library/papers/16896009PubMed
1517136094Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.Nature2006https://conductscience.org/library/papers/17136094PubMed
1610611684Genetic instability and darwinian selection in tumours.Trends Cell Biol1999https://conductscience.org/library/papers/10611684PubMed
1712527885ATM is a target for positive regulation by E2F-1.Oncogene2003https://conductscience.org/library/papers/12527885PubMed
189529249ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.Cell1998https://conductscience.org/library/papers/9529249PubMed
1912381663Deregulated G1-cyclin expression induces genomic instability by preventing efficient pre-RC formation.Genes Dev2002https://conductscience.org/library/papers/12381663PubMed
2018772396An integrated genomic analysis of human glioblastoma multiforme.Science2008https://conductscience.org/library/papers/18772396PubMed

See all 60 referencesDownload CSV of references

Cited by1,355

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,826 citations.

PMIDTitleJournalYearIn PapersSource
42984918Targeting ATM Kinase in Cancer-A Comprehensive Review.Oncol Res2026https://conductscience.org/library/papers/42984918PubMed
42957698PrimPol toggled by ATR modulates fork slowing and repriming under oncogenic KRAS-induced replication stress.Nat Commun2026https://conductscience.org/library/papers/42957698PubMed
42955439Treatment options after tumor resistance: exploiting vulnerabilities from genome to tumor microenvironment.Cancer Metastasis Rev2026https://conductscience.org/library/papers/42955439PubMed
42938371
Diagnostic and Clinical Considerations in Myeloid Neoplasms with del(5q): Distinguishing Myelodysplastic Neoplasm with Low Blasts and del(5q) from Myeloid Neoplasms with del(5q) Post-Cytotoxic Therapy.
Genes (Basel)2026https://conductscience.org/library/papers/42938371PubMed
42927053Biological Mechanisms Underlying the Adverse Health Consequences of Human Circadian Misalignment from Night Shift Work.Curr Sleep Med Rep2026https://conductscience.org/library/papers/42927053PubMed
42891872Histotype and molecular subtype integration in epithelial ovarian cancer: implications for targeted treatment.Cancer Metastasis Rev2026https://conductscience.org/library/papers/42891872PubMed
42806616CCNE1: A Cell Cycle Regulator That Influences Tumor Progression.Cancer Med2026https://conductscience.org/library/papers/42806616PubMed
42775253Hesperidin reduces genomic instability in glioblastoma cells and is associated with reduced HNRNPA2B1/m6A levels.Front Pharmacol2026https://conductscience.org/library/papers/42775253PubMed
42765004Nanomaterial-driven spatiotemporal autophagy modulation: The dual-edged sword in precision cancer therapy.Acta Pharm Sin B2026https://conductscience.org/library/papers/42765004PubMed
42755572SYTL5 drives malignant progression in differentiated thyroid carcinoma: unveiling its regulatory mechanisms.Front Oncol2026https://conductscience.org/library/papers/42755572PubMed
42738930Time-Dependent Multimechanistic Antitumor Effects of Olive Oil Phenolics in a Triple-Negative Breast Cancer Mouse Model.Nutrients2026https://conductscience.org/library/papers/42738930PubMed
42652167EFEMP2 Is Associated with Shelterin-Related DNA Damage Repair, Immune Microenvironment Features, and Prognosis in Glioblastoma.Biomedicines2026https://conductscience.org/library/papers/42652167PubMed
42645345The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC.Curr Oncol2026https://conductscience.org/library/papers/42645345PubMed
42627676Loss of CYLD on Chromosome 16q Impairs Homologous Recombination and Genomic Stability Through TIRR Degradation.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42627676PubMed
42601667Ionizing Radiation and Ultraviolet Light Irradiation-Associated DNA Damage Increasing Genomic Instability Risk.Cancer Sci2026https://conductscience.org/library/papers/42601667PubMed
42567948Causal graph neural networks for healthcare.Nat Biomed Eng2026https://conductscience.org/library/papers/42567948PubMed
42564453Saccharomyces cerevisiae in cancer research: modeling tumor biology and enabling drug discovery.Microb Cell2026https://conductscience.org/library/papers/42564453PubMed
42543507Lock-Open: An AND Logic-Gated, Entropy-Driven DNA Nanowalker for Highly Sensitive Detection of UDG and APE1 Activities in Hepatocellular Carcinoma.Adv Healthc Mater2026https://conductscience.org/library/papers/42543507PubMed
42533686Reactive Oxygen Species: Molecular Mechanisms, Cellular Targets, and Implications for Genomic Stability.Biomed Res Int2026https://conductscience.org/library/papers/42533686PubMed
42513228Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms.Molecules2026https://conductscience.org/library/papers/42513228PubMed

See all 1,355 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
CDKN2A1029PubTator's text mininghttps://conductscience.org/library/genes/1029NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20177397

GET https://conductscience.org/api/papers/v1/20177397/references?page=2